Pfizer recalls some batches of blood pressure drug over carcinogen presence

✔ Fact Checked by TDPel News Desk

By Lola Smith

Published: April 23, 2022 | 7:26 AM GMT

Pfizer last month also recalled some batches of another blood pressure drug Accuretic and two authorized cheaper versions due to the presence of the possible carcinogen.

Pfizer said on Friday it was voluntarily recalling five batches of its Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine.

The drug-maker said it was not aware of any reports of adverse events related to the recalled batches, which were distributed in the United States and Puerto Rico from December 2019 to April 2022.

Pfizer Canada also recalled all lots of three doses of Accupril on Thursday after finding the same impurity to be above acceptable levels.

Pfizer said there was no immediate risk to patients taking this medication, in which the agent, a nitrosamine, was found.

Nitrosamines are common in water and foods but exposure above acceptable levels over long periods of time could increase the risk of cancer.

We are taking you to the next article automatically...You can cancel it below or click Load Now to read it now!

About Lola Smith

Lola Smith is a highly experienced writer and journalist with over 25 years of experience in the field. Her special interest lies in journalistic writeups, where she can utilize her skills and knowledge to bring important stories to the public eye. Lola’s dedication to her craft is unparalleled, and she writes with passion and precision, ensuring that her articles are informative, engaging, and thought-provoking. She lives in New York, USA.